PERFORMANCE STOCK UNIT AGREEMENT PURSUANT TO THE CELGENE CORPORATION 2008 STOCK INCENTIVE PLAN (Amended and Restated as of April 15, 2015) (Amended & Restated as of June 15, 2016)Performance Stock Unit Agreement • February 10th, 2017 • Celgene Corp /De/ • Pharmaceutical preparations • Delaware
THIS AGREEMENT (the “Agreement”), is made as of the %%OPTION_DATE,’DD-Month-YYYY’%-% (the “Grant Date”), by and between Celgene Corporation, a Delaware corporation (the “Company”) and %%FIRST_NAME%-% %%LAST_NAME%-% (the “Participant”). Capitalized terms in this Agreement that are not defined shall have the meaning set forth in the Celgene Corporation 2008 Stock Incentive Plan, as amended and restated as of April 15, 2015, and as further amended as of June 15, 2016 (the “Plan”).
RESTRICTED STOCK UNIT AGREEMENT PURSUANT TO THE CELGENE CORPORATION 2008 STOCK INCENTIVE PLAN (Amended & Restated as of April 15, 2015) (As Further Amended as of June 15, 2016) (for US employees)Restricted Stock Unit Agreement • February 10th, 2017 • Celgene Corp /De/ • Pharmaceutical preparations • Delaware
THIS AGREEMENT (the “Agreement”), is made as of the %%OPTION_DATE,'DD/MM/YYYY'%-% (the “Grant Date”), by and between Celgene Corporation, a Delaware corporation (the “Company”) and %%FIRST_NAME%-% %%LAST_NAME%-% (the “Participant”). Capitalized terms in this Agreement that are not defined shall have the meaning set forth in the Celgene Corporation 2008 Stock Incentive Plan, as amended and restated as of April 15, 2015, and as further amended as of June 15, 2016 (the “Plan”).
CELGENE CORPORATION STOCK OPTION AGREEMENT PURSUANT TO THE (Amended & Restated as of April 15, 2015) (As Further Amended as of June 15, 2016)Stock Option Agreement • February 10th, 2017 • Celgene Corp /De/ • Pharmaceutical preparations
THIS CERTIFIES that, pursuant to the Celgene Corporation 2008 Stock Incentive Plan, as amended and restated as of April 15, 2015, and as further amended as of June 15, 2016, annexed hereto as Exhibit A (the “Plan”), %%FIRST_NAME%-% %%LAST_NAME%-% (the (“Optionee”) was granted, on %%OPTION_DATE,’DD-Month-YYYY’%-% (the “Grant Date”) an Option (the “Option”) to purchase %%TOTAL_SHARES_GRANTED,’999,999,999’%-% shares of Common Stock, par value $.01 per share, of Celgene Corporation, Option Number %%OPTION_NUMBER%-% at a price of US%%OPTION_PRICE,’$999,999,999.99’%-% per share, subject to and under the terms and conditions set forth herein and in the Plan, which are deemed incorporated herein by reference. The Option granted pursuant hereto is made as of the Grant Date and shall be governed by the terms of Plan, as amended and restated as of April 15, 2015, and as further amended as of June 15, 2016. These Options are granted as non-qualified (NQ) stock options, according to the vesting det
